article_metadata: Huijuan Fang Fengchuan Zhang Wenjun Lin Yuqi Jiang Qingwu Liu Dingquan Yang
article_metadata: 10.3389/fimmu.2024.1395288
article_metadata: Front Immunol
article_metadata: 2024 Jun 6:15:1395288.
article_metadata: alopecia areata atopic dermatitis autoimmunity baricitinib dupilumab
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/38903518/
article_metadata: Alopecia Areata / diagnosis Alopecia Areata / drug therapy Antibodies, Monoclonal, Humanized / administration & dosage Antibodies, Monoclonal, Humanized / adverse effects Antibodies, Monoclonal, Humanized / therapeutic use Azetidines / administration & dosage Azetidines / adverse effects Azetidines / therapeutic use Dermatitis, Atopic / drug therapy Purines / administration & dosage Purines / adverse effects Pyrazoles / administration & dosage Pyrazoles / adverse effects Pyrazoles / therapeutic use Sulfonamides / administration & dosage Sulfonamides / adverse effects Sulfonamides / therapeutic use
article_metadata: Alopecia Areata / diagnosis Alopecia Areata / drug therapy Antibodies, Monoclonal, Humanized / administration & dosage Antibodies, Monoclonal, Humanized / adverse effects Antibodies, Monoclonal, Humanized / therapeutic use Azetidines / administration & dosage Azetidines / adverse effects Azetidines / therapeutic use Dermatitis, Atopic / drug therapy Purines / administration & dosage Purines / adverse effects Pyrazoles / administration & dosage Pyrazoles / adverse effects Pyrazoles / therapeutic use Sulfonamides / administration & dosage Sulfonamides / adverse effects Sulfonamides / therapeutic use Case Reports Child Drug Therapy, Combination Female Humans Severity of Illness Index Treatment Outcome baricitinib Purines Azetidines Pyrazoles Sulfonamides dupilumab Antibodies, Monoclonal, Humanized
article_metadata: PMC11187300
article_metadata: 38903518
article_metadata: Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children
article_metadata: 2024